Retina II
My Session Status
- Describe new advances in macular degeneration with geographic atrophy, neovascular macular degeneration and diabetic retinopathy
- Integrate multi-modal imaging in the management of retinal detachment repair
- Assess the impact of COVID-19 on retinal practices
Sub Sessions
Authors: Varun Chaudhary, Frank G. Holz, Edoardo Midena, Eric Souied, Sebastian Wolf, George Lambrou, Tobias Machewitz, Paul Mitchell. Disclosure Block: V. Chaudhary: Membership on advisory boards or speakers’ bureaus; Name of for-profit or not-for-profit organization(s); Alcon Laboratories, Bayer Healthcare, Novartis Pharma AG. Membership on advisory boards or speakers’ bureaus; Description of relationship(s); Served as a Scientific Advisor, ...
Authors: Aditya Bansal, Wei Wei Lee, Tina Felfeli, Rajeev H. Muni. Disclosure Block: A. Bansal: None. W. Lee: None. T. Felfeli: None. R.H. Muni: None. Abstract Body: Purpose: To assess the stages of retinal re-attachment using swept-source optical coherence tomography (SS-OCT) for rhegmatogenous retinal detachment (RRD). Study D...
Authors: Mélanie Hébert, Eunice You, Jérôme Garneau, Serge Bourgault, Mathieu Caissie, Éric Tourville, Ali Dirani. Disclosure Block: M. Hébert: None. E. You: None. J. Garneau: None. S. Bourgault: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Novartis, Bayer. Any direct financial payments including receipt of honoraria; Desc...
Authors: Raman Tuli, Peter A. Campochiaro, Natasha Singh, David Kardatzke, Steven Blotner, Shienal Patel, Giulio Barteselli. Disclosure Block: R. Tuli: Any direct financial payments including receipt of honoraria; Name of for-profit or not-for-profit organization(s); Hoffmann La Roche. Any direct financial payments including receipt of honoraria; Description of relationship(s); Consultant. Funded grants or clinical trials; Name of for-profit or...
